section name header

Use and Dosing

Adult Dosingnavigator.gif

Primary immunodeficiency

Note: Administer at the minimum infusion rate practicable in patients at risk of renal dysfunction or thrombotic events. Before initiating therapy, ensure that patients with pre-existing renal insufficiency are not volume-depleted and discontinue therapy if renal function deteriorates

Pediatric Dosingnavigator.gif


[Outline]

Indications

Contraindications

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions

Cautions: Use cautiously in:

Pregnancy/Breast Feeding

Pregnancy Category:C

Breastfeeding: It is not known if the drug is excreted in breast milk; safety unknown

Adverse Reactions

Clinical Pharmacology

`

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

Flebogamma DIF

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

flag_uk32.png

UK Trade Name(s)

UK Availability

Flebogamma DIF

flag_australia32.png

Australian Trade Name(s)

Australian Availability


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Immunologic

Immunoglobulins